Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

Persistent Negative Attitude Can Undo Effectiveness of Exposure Therapy for Phobias

27.02.2013
Because confronting fear won’t always make it go away, researchers suggest that people with phobias must alter memory-driven negative attitudes about feared objects or events to achieve a more lasting recovery from what scares them the most.

Ohio State University psychology researchers determined that people who retained negative attitudes about public speaking after exposure therapy were more likely to experience a return of their fear a month later than were people whose attitudes were less negative. The fear returned among those with unchanged attitudes even if they showed improvement during the treatment.

The scientists also developed a way to evaluate attitudes immediately after the completion of exposure therapy. The tool both confirms their argument that persistent negative attitudes can undo therapy’s effects and offers clinicians a way to assess whether a few more sessions of treatment might be in order.

It is well known among psychologists that the return of fear is common in the months after exposure therapy for people with phobias. The Ohio State scientists say this could be because the treatment tends to focus on building skills to fight the fear. What sometimes remains unaddressed is the automatic negative attitude that plagues the average person with a phobia.

These attitudes are based on such a powerful association between a feared object – say, a spider – and a negative feeling about the species so strong that a person with a phobia can’t see or even think about a spider without experiencing that automatic negative reaction, which leads to avoidance behavior.

“In exposure therapy, people can learn some skills to control the negativity and fear that got automatically activated and be able to perform well despite that activation. But if that’s all that happens, then the person may still very likely have a problem because there will be situations where their confidence will end up being eroded, they won’t be able to manage their fear and they will have a failure experience,” said Russell Fazio, professor of psychology at Ohio State and a senior author of the study.

“The other thing treatment can do is actually change the likelihood that that negativity or fear is automatically activated when one is placed in that situation. We argue that treatment will provide more persistent improvement if it succeeds in changing that attitude representation.

“Overall, we’d like to see if clinicians can get people to view success in therapy not as a limited experience, but instead as an opportunity to really learn something about themselves. To the extent that we promote that generalization, we’re going to promote attitude change,” he said.

Phobias affect nearly 9 percent of American adults, or about 20 million people, according to the National Institute of Mental Health.

The research is published in a recent issue of the journal Behaviour Research and Therapy.

The study involved 40 adults ranging in age from 18 to 46 years who met criteria for social anxiety disorder in the context of public speaking. Fazio and colleagues measured their fear and attitudes with a variety of questionnaires, and also recorded participants’ heart rate and subjective units of distress, a rating scale from no anxiety to extreme anxiety, while they were delivering a speech at various time points in the study.

In the treatment, each participant was given three minutes to prepare a five-minute speech on two topics selected at random. They delivered the speeches without notes before a small live audience and in front of a video camera. The overall treatment included an initial discussion about public speaking anxiety and four of these exposure trials.

Participants also completed the critical assessment tool, called the Personalized Implicit Association Test, before and after treatment. The test was modified specifically for this study based on Fazio’s longstanding research program on these kinds of automatic evaluations.

Statistical analysis showed that on average, all participants’ fear was reduced after completion of the treatment based on numerous measures. But one month later, an average of 49.2 percent of participants had experienced a return of their fear – and results of the association test showed that people with persistent negative attitudes were the ones whose fear of public speaking returned.

Two measures in particular were traced to participants whose attitudes remained negative – heart rate and anticipatory anxiety. Both measures were more likely to be elevated at the one-month follow-up in participants whose post-treatment association tests indicated that they still felt negative about public speaking.

Why is such an assessment beneficial? Fazio noted that people who devote time to a treatment program want to believe it’s working. They also tend to want to please their therapists.

“There is a lot of pressure to believe and to report that it is going well,” Fazio said. “Another part is people are not very well calibrated at reporting the extent to which they’ve improved. So there’s value in having another way of getting inside the person’s head.”

What this study does not reveal, however, is who is more likely to retain the automatic negative attitude and whose attitude is more likely to change as a function of treatment.

Exposure therapy is considered effective because it forces people with phobias to stop avoiding what they fear and allows them to learn that they can encounter what they fear and survive. Fazio and colleagues hope to extend this work by developing supplemental components in exposure therapy that would more explicitly attack the activation of negative attitudes.

This work was supported by the National Institute of Mental Health.

Co-authors include Michael Vasey, Casaundra Harbaugh, Adam Buffington and Christopher Jones, all of Ohio State’s Department of Psychology.

Contact: Russell Fazio, (614) 688-5408; Fazio.11@osu.edu
Written by Emily Caldwell, (614) 292-8310; Caldwell.151@osu.edu

Russell Fazio | EurekAlert!
Further information:
http://www.osu.edu

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Mit Barcodes der Zellentwicklung auf der Spur

Darüber, wie sich Blutzellen entwickeln, existieren verschiedene Auffassungen – sie basieren jedoch fast ausschließlich auf Experimenten, die lediglich Momentaufnahmen widerspiegeln. Wissenschaftler des Deutschen Krebsforschungszentrums stellen nun im Fachjournal Nature eine neue Technik vor, mit der sich das Geschehen dynamisch erfassen lässt: Mithilfe eines „Zufallsgenerators“ versehen sie Blutstammzellen mit genetischen Barcodes und können so verfolgen, welche Zelltypen aus der Stammzelle hervorgehen. Diese Technik erlaubt künftig völlig neue Einblicke in die Entwicklung unterschiedlicher Gewebe sowie in die Krebsentstehung.

Wie entsteht die Vielzahl verschiedener Zelltypen im Blut? Diese Frage beschäftigt Wissenschaftler schon lange. Nach der klassischen Vorstellung fächern sich...

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Forscher entwickeln maisförmigen Arzneimittel-Transporter zum Inhalieren

Er sieht aus wie ein Maiskolben, ist winzig wie ein Bakterium und kann einen Wirkstoff direkt in die Lungenzellen liefern: Das zylinderförmige Vehikel für Arzneistoffe, das Pharmazeuten der Universität des Saarlandes entwickelt haben, kann inhaliert werden. Professor Marc Schneider und sein Team machen sich dabei die körpereigene Abwehr zunutze: Makrophagen, die Fresszellen des Immunsystems, fressen den gesundheitlich unbedenklichen „Nano-Mais“ und setzen dabei den in ihm enthaltenen Wirkstoff frei. Bei ihrer Forschung arbeiteten die Pharmazeuten mit Forschern der Medizinischen Fakultät der Saar-Uni, des Leibniz-Instituts für Neue Materialien und der Universität Marburg zusammen Ihre Forschungsergebnisse veröffentlichten die Wissenschaftler in der Fachzeitschrift Advanced Healthcare Materials. DOI: 10.1002/adhm.201700478

Ein Medikament wirkt nur, wenn es dort ankommt, wo es wirken soll. Wird ein Mittel inhaliert, muss der Wirkstoff in der Lunge zuerst die Hindernisse...

Im Focus: Exotische Quantenzustände: Physiker erzeugen erstmals optische „Töpfe" für ein Super-Photon

Physikern der Universität Bonn ist es gelungen, optische Mulden und komplexere Muster zu erzeugen, in die das Licht eines Bose-Einstein-Kondensates fließt. Die Herstellung solch sehr verlustarmer Strukturen für Licht ist eine Voraussetzung für komplexe Schaltkreise für Licht, beispielsweise für die Quanteninformationsverarbeitung einer neuen Computergeneration. Die Wissenschaftler stellen nun ihre Ergebnisse im Fachjournal „Nature Photonics“ vor.

Lichtteilchen (Photonen) kommen als winzige, unteilbare Portionen vor. Viele Tausend dieser Licht-Portionen lassen sich zu einem einzigen Super-Photon...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics
Veranstaltungen

Einblicke ins menschliche Denken

17.08.2017 | Veranstaltungen

Eröffnung der INC.worX-Erlebniswelt während der Technologie- und Innovationsmanagement-Tagung 2017

16.08.2017 | Veranstaltungen

Sensibilisierungskampagne zu Pilzinfektionen

15.08.2017 | Veranstaltungen

 
VideoLinks
B2B-VideoLinks
Weitere VideoLinks >>>
Aktuelle Beiträge

Scharfe Röntgenblitze aus dem Atomkern

17.08.2017 | Physik Astronomie

Fake News finden und bekämpfen

17.08.2017 | Interdisziplinäre Forschung

Effizienz steigern, Kosten senken!

17.08.2017 | Messenachrichten